Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PRQR

ProQR Therapeutics N.V

May 14 • 04:00PM ET

1.65

-0.05 -2.94 %

Healthcare • Biotechnology • Netherlands • Micro • NASD

Peers: WVE QURE ARWR EDIT VYGR

| Held by: QQQS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.50	Insider Own	32.21%	Shs Outstand	105.36M	Perf Week	4.43%
Market Cap	173.85M	Forward P/E	-	EPS next Y	-0.70	Insider Trans	0.00%	Shs Float	71.43M	Perf Month	-17.09%
Enterprise Value	96.19M	PEG	-	EPS next Q	-0.15	Inst Own	36.02%	Short Float	1.18%	Perf Quarter	18.71%
Income	-52.71M	P/S	11.19	EPS this Y	-30.73%	Inst Trans	-1.04%	Short Ratio	1.55	Perf Half Y	-23.61%
Sales	15.53M	P/B	4.01	EPS next Y	-14.37%	ROA	-37.92%	Short Interest	0.84M	Perf YTD	-18.32%
Book/sh	0.41	P/C	1.86	EPS next 5Y	9.63%	ROE	-81.98%	52W High	3.10 -46.77%	Perf Year	6.45%
Cash/sh	0.89	P/FCF	-	EPS past 3/5Y	21.80% 15.68%	ROIC	-98.02%	52W Low	1.33 24.06%	Perf 3Y	-14.95%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	68.13% -	Gross Margin	79.71%	Volatility	7.26% 8.25%	Perf 5Y	-74.26%
Dividend TTM	-	EV/Sales	6.19	EPS Y/Y TTM	-44.36%	Oper. Margin	-346.94%	ATR (14)	0.14	Perf 10Y	-66.05%
Dividend Ex-Date	-	Quick Ratio	2.48	Sales Y/Y TTM	-23.73%	Profit Margin	-339.39%	RSI (14)	49.56	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.48	EPS Q/Q	-47.57%	SMA20	0.50%	Beta	0.08	Target Price	9.04
Payout	-	Debt/Eq	0.36	Sales Q/Q	-49.99%	SMA50	-2.56%	Rel Volume	0.66	Prev Close	1.70
Employees	-	LT Debt/Eq	0.24	Earnings	May 12 BMO	SMA200	-16.95%	Avg Volume	544.96K	Price	1.65
IPO	Sep 18, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.12% -54.37%	Trades		Volume	360,261	Change	-2.94%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)